Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
Články v Klinické onkologii
- Hodnocení FDG PET nálezů na plicích po léčbě Hodgkinova lymfomu.
- Hodnocení mukosity u pacientů léčených vysokodávkovanou chemoterapií s podporou autologních krvetvorných buněk a jeho význam pro odhad perorálního příjmu a dalších faktorů morbidity a mortality
- Indikace k alogenním a autologním transplantacím krvetvorných buněk. Doporučení České hematologické společnosti ČLS JEP a České onkologické společnosti ČLS JEP.
- Léčba Hodgkinovy choroby v roce 2002
- Léčba pacientů s relabovaným/refraktérním Hodgkinovým lymfomem
- Model populačního klinického registru umožň ujícího hodnocení léčebné péče: projekt ALERT (akutní leukemie-klinický registr)
- Význam klinického registru nemocných s lymfomy – přínos, možnosti a limitace
Léčebné postupy
- 1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
- 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
- 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
- 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
- Acute GvHD Diagnosis and Management
- Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Acute Lymphoblastic Leukemia (Version 1.2017)
- Acute Myeloid Leukemia (Version 3.2017)
- Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
- Adolescent and Young Adult (AYA) Oncology (Version 1.2018)
- Adult Cancer Pain (Version 2.2017)
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
- American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer
- American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients with Advanced Non-Small Cell Lung Cancer Considering First-Line EGFR Tyrosine-Kinase Inhibitor (TKI) Therapy
- American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care into Standard Oncology Care
- American Society of Clinical Oncology-American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
- American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
- Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Anal Carcinoma (Version 2.2017)
- Antiemesis (Version 2.2017)
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- Basal cell skin cancer (Version 1.2017)
- BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
- Biliary cancer
- Bladder Cancer (Version 5.2017)
- Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
- Bone Cancer (Version 2.2017)
- Bone Health in Cancer Patients
- Bone sarcomas
- Breast Cancer (Version 2.2017)
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update
- Breast Cancer Risk Reduction (Version 1.2017)
- Breast Cancer Screening and Diagnosis (Version 1.2017)
- Cancer Associated Venous Thromboembolic Disease (Version 1.2017)
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Cancer- and Chemotherapy-Induced Anemia (Version 1.2018)
- Cancer-Related Fatigue (Version 2.2017)
- Cancer, pregnancy and fertility
- Central Nervous System Cancers (Version 1.2017)
- Cervical cancer
- Cervical Cancer (Version 1.2017)
- Cervical Cancer Screening (Version 1.2014)
- Colon Cancer (Version 2.2017)
- Colorectal Cancer Screening (Version 1.2017)
- Cutaneous melanoma
- Dermatofibrosarcoma Protuberans (Version 1.2017)
- Diagnosis and Management of Acute Myeloid Leukemia in Adults
- Diagnostika a léčba mnohočetného myelomu
- Diffuse large B-cell lymphoma (DLBCL)
- Distress Management (Version 1.2017)
- Doporučený postup paliativní péče v MOÚ
- Doporučený postup pro histologické vyšetření karcinomu plic
- EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.
- EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma.
- EORTC - ISCL and consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
- ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia
- ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
- Esophageal and Esophagogastric Junction Cancers (Version 2.2017)
- European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
- Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
- Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines
- Fertility Preservation in Patients with Cancer: American Society of Clinical Oncology Guideline Update
- Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- Gastric Cancer (Version 2.2017)
- Gastric Cancer: ESMO Clinical Practice Guidelines
- Gastric marginal zone lymphoma of MALT type
- Gastrointestinal stromal tumours
- Genetic/Familial High-Risk Assessment: Colorectal (Version 2.2017)
- Genetic/Familial High-Risk Assessment:Breast and Ovarian (Version 2.2017)
- Guideline for the diagnosis and management of myelofibrosis
- Guideline gynekologických zhoubných nádorů – Primární komplexní léčba operabilních stadií zhoubných nádorů vulvy
- Guideline on the investigation and management of adults and children presenting with thrombocytosis
- Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma
- Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology
- Guideline update for MASCC & ESMO in the prevention of chemotherapy and radiotherapy-induced nausea and vomiting
- Guidelines for the diagnosis and management of adult myelodysplastic syndromes
- Guidelines for the diagnosis and management of multiple myeloma 2013
- Guidelines for the first line management of classical Hodgkin lymphoma
- Guidelines for the investigation and management of mantle cell lymphoma
- Guidelines on obtaining consent for systemic anti-cancer therapy in adults
- Guidelines on the investigation and management of Chronic Lymphocytic Leukaemia
- Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Hairy Cell Leukemia (Version I.2018)
- Head and Neck Cancers (Version 2.2017). Mucosal Melanoma
- Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines
- High-grade malignant glioma
- Hodgkin Lymphoma (Version 1.2017)
- Hodgkin's lymphoma
- Chemotherapy and Targeted Therapy for Women with HER2 Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- Chronic GvHD Diagnosis and Management
- Chronic lymphocytic leukaemia
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma)(Version 1.2018)
- Chronic myeloid leukaemia
- Chronic Myeloid Leukemia (Version 1.2018)
- Kidney Cancer (Version 2.2017)
- Konsenzus pro testování prediktivních markerů u karcinomu plic
- Léčebná doporučení pro chronickou lymfocytární leukémii (CLL)
- Léčebné postupy v hematologii (tzv. "Červená kniha")
- Lung Cancer Screening (Version 1.2015)
- Malignant pleural mesothelioma
- Malignant Pleural Mesothelioma (Version 2.2017)
- Management of AML in Pregnancy
- Management of cytomegalovirus infection in haemopoietic stem cell transplantation
- Management of Diffuse Large B-cell Lymphoma
- Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
- Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines
- Management of oral and gastrointestinal mucosal injury
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Management of Tumour Lysis Syndrome in Adults and Children with Haematological Malignancies
- Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology Guideline
- Melanoma (Version 1.2017)
- Merkel Cell Carcinoma (Version 1.2017)
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Metastatic non-small-cell lung cancer (NSCLC)
- Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010
- Minimální doporučená léčebná strategie u Hodgkinova lymfomu
- Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
- Multiple myeloma
- Multiple Myeloma (Version 3.2017)
- Myelodysplastic syndromes
- Myelodysplastic Syndromes (Version 2.2017)
- Myeloid Growth Factors (Version 1.2017)
- Myeloproliferative Neoplasms (Version I.2018)
- Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Neuroendocrine Tumors (Version 3.2017)
- New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel
- Newly diagnosed and relapsed epithelial ovarian carcinoma
- Newly diagnosed and relapsed follicular lymphoma
- Newly diagnosed and relapsed mantle cell lymphoma
- Non-Small Cell Lung Cancer (Version 8.2017)
- Occult Primary (Version 2.2017)
- Older Adult Oncology (Version 2.2017)
- Organ Specific Management and Supportive Care in Chronic Graft versus Host Disease
- Ovarian Cancer. Including Fallopian Tube Cancer and Primary Peritoneal Cancer (Version 2.2017)
- Palliative Care (Version 2.2017)
- Pancreatic Adenocarcinoma (version 2.2017)
- Penile Cancer (Version 2.2017)
- Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
- Prevention and Treatment of Cancer-Related Infections (Version 2.2017)
- Primary breast cancer
- Primary Cutaneous B-Cell Lymphomas (Version 2.2017)
- Prostate Cancer (Version 2.2017)
- Prostate Cancer Early Detection (Version 1.2017)
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Prostate cancer: ESMO Consensus Conference Guidelines 2012
- Protokol pro léčbu karcinomu hrdla děložního
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
- Rectal Cancer (Version 3.2017)
- Rectal Cancer: ESMO Clinical Practice Guidelines
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen
- Revised Guidelines for the Diagnosis and Therapy of Hairy Cell Leukaemia
- Screening and Management of Late and Long-term Consequences of Myeloma and its Treatment
- Screening for Prostate Cancer with Prostate-Specific Antigen (PSA) Testing: American Society of Clinical Oncology Provisional Clinical Opinion
- Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation
- Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
- Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- Small Cell Lung Cancer (Version 3.2017)
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Smoking Cessation (Version 2.2017)
- Soft tissue and visceral sarcomas
- Soft Tissue Sarcoma (Version 2.2017)
- Squamous Cell Skin Cancer (Version 1.2017)
- Standard léčebného plánu - Karcinom endometria
- Survivorship (Version 2.2017)
- Systemic Light Chain Amyloidosis (Version 1.2017)
- Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
- T-Cell Lymphomas (Version 25.2017)
- Testicular Cancer (Version 2.2017)
- Testicular seminoma and non-seminoma
- The diagnosis of post-transplant lymphoproliferative disorders
- The management of post-transplant lymphproliferative disorder
- The role of CT screening for Lung Cancer in clinical practice. The evidence based practice guideline of the American College of Chest Physicians and the American Society for Clinical Oncology
- Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Thymomas and Thymic Carcinomas (Version 1.2017)
- Thyroid Carcinoma (Version 2.2017)
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
- Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline
- Uterine Neoplasms (Version 3.2017)
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- Vulvar Cancer (Sqamous Cell Carcinoma) (Version 1.2017)
- Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Waldenströms Macroglobulinemia/Lymphoplasmacytic Lymphoma (Version 1.2017)
